Cargando…

Preliminary study on the effects of pergolide on left ventricular function in the horses with pituitary pars intermedia dysfunction

BACKGROUND: Pituitary pars intermedia dysfunction (PPID), a neurodegenerative disease leading to reduced dopamine production, is a common disease in aged horses. The treatment is based on administration of the dopamine agonist pergolide. This drug has been related to valvular fibrosis in humans, but...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gehlen, Heidrun, Fisch, Judith, Merle, Roswitha, Trachsel, Dagmar S.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Korean Society of Veterinary Science 2021
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8460455/ https://www.ncbi.nlm.nih.gov/pubmed/34553515 http://dx.doi.org/10.4142/jvs.2021.22.e64

Ejemplares similares

Plasma Amino Acids in Horses Suffering from Pituitary Pars Intermedia Dysfunction
por: Stoeckle, Sabita Diana, et al.
Publicado: (2022)

Restoring pars intermedia dopamine concentrations and tyrosine hydroxylase expression levels with pergolide: evidence from horses with pituitary pars intermedia dysfunction
por: Fortin, Jessica S., et al.
Publicado: (2020)

Pituitary Pars Intermedia Dysfunction and Metabolic Syndrome in Donkeys
por: Gehlen, Heidrun, et al.
Publicado: (2020)

Pituitary Pars Intermedia Dysfunction (PPID) in Horses
por: Kirkwood, Naomi C., et al.
Publicado: (2022)

Can Endocrine Dysfunction Be Reliably Tested in Aged Horses That Are Experiencing Pain?
por: Gehlen, Heidrun, et al.
Publicado: (2020)

The Gingiva of Horses With Pituitary Pars Intermedia Dysfunction: A Macroscopic Anatomical Evaluation
por: Nitzsche, Anne Maria, et al.
Publicado: (2022)

Periodontal structures in horses with pituitary pars intermedia dysfunction: A histological evaluation
por: Zapf, Anne Maria, et al.
Publicado: (2023)

Investigation of Single and Paired Measurements of Adrenocorticotropic Hormone for the Diagnosis of Pituitary Pars Intermedia Dysfunction in Horses
por: Rendle, D.I., et al.
Publicado: (2014)

Evaluation of combined testing to simultaneously diagnose pituitary pars intermedia dysfunction and insulin dysregulation in horses
por: Horn, Remona, et al.
Publicado: (2019)

Evaluating Horse Owner Expertise and Professional Use of Auxiliary Reins during Horse Riding
por: Gehlen, Heidrun, et al.
Publicado: (2021)

Effects of Advanced Age, Pituitary Pars Intermedia Dysfunction and Insulin Dysregulation on Serum Antioxidant Markers in Horses
por: Żak, Agnieszka, et al.
Publicado: (2020)

Association between Cardiac Auscultation and Echocardiographic Findings in Warmblood Horses
por: Hövener, Jakob, et al.
Publicado: (2021)

Dysregulation of Cortisol Metabolism in Equine Pituitary Pars Intermedia Dysfunction
por: Morgan, Ruth A, et al.
Publicado: (2018)

Repeatability of a thyrotropin‐releasing hormone stimulation test for diagnosis of pituitary pars intermedia dysfunction in mature horses
por: Kam, Yan Ning, et al.
Publicado: (2021)

Plasma Amino Acid Concentration in Obese Horses with/without Insulin Dysregulation and Laminitis
por: Stoeckle, Sabita Diana, et al.
Publicado: (2022)

Evaluation of Stress Response under a Standard Euthanasia Protocol in Horses Using Analysis of Heart Rate Variability
por: Gehlen, Heidrun, et al.
Publicado: (2020)

Comparison of Sources and Methods for the Isolation of Equine Adipose Tissue-Derived Stromal/Stem Cells and Preliminary Results on Their Reaction to Incubation with 5-Azacytidine
por: Trachsel, Dagmar S., et al.
Publicado: (2022)

Equine pituitary pars intermedia dysfunction: current perspectives on diagnosis and management
por: Spelta, Caroline W
Publicado: (2015)

Equine pituitary pars intermedia dysfunction: a spontaneous model of synucleinopathy
por: Fortin, Jessica S., et al.
Publicado: (2021)

Clinical implications of using adrenocorticotropic hormone diagnostic cutoffs or reference intervals to diagnose pituitary pars intermedia dysfunction in mature horses
por: Horn, Remona, et al.
Publicado: (2020)

Prospective Case Series of Clinical Signs and Adrenocorticotrophin (ACTH) Concentrations in Seven Horses Transitioning to Pituitary Pars Intermedia Dysfunction (PPID)
por: Kirkwood, Naomi C., et al.
Publicado: (2022)

Association between Disease Severity, Heart Rate Variability (HRV) and Serum Cortisol Concentrations in Horses with Acute Abdominal Pain
por: Gehlen, Heidrun, et al.
Publicado: (2020)

Catecholamine Metabolism in a Shetland Pony with Suspected Pheochromocytoma and Pituitary Pars Intermedia Dysfunction
por: Fouché, N., et al.
Publicado: (2016)

Profiles of pro-opiomelanocortin and encoded peptides, and their processing enzymes in equine pituitary pars intermedia dysfunction
por: Carmalt, James L., et al.
Publicado: (2018)

Multilineage Differentiation Potential of Equine Adipose-Derived Stromal/Stem Cells from Different Sources
por: Stage, Hannah J., et al.
Publicado: (2023)

Pituitary pars intermedia dysfunction (equine Cushing’s disease) in a Thoroughbred stallion: a single report
por: HATAZOE, Takashi, et al.
Publicado: (2016)

Subclinical Left Ventricular Dysfunction in Children and Adolescence With Thalassemia Intermedia
por: Isa Tafreshi, Roya, et al.
Publicado: (2022)

Pergolide Mesilate May Improve Fatigue in Patients with Parkinson’s Disease
por: Abe, Kazuo, et al.
Publicado: (2002)

Seroepidemiological Survey of West Nile Virus Infections in Horses from Berlin/Brandenburg and North Rhine-Westphalia, Germany
por: Bergmann, Felicitas, et al.
Publicado: (2022)

Cytological Differences in the Localization of Glucocorticoid Receptor-Like Imnunoreactivity in the Normal and Transplanted Pituitary Pars Intermedia
por: Iturriza, Fermlín C., et al.
Publicado: (1992)

Markers for internal neoplasia in the horse
por: Drozdzewska, Karolina, et al.
Publicado: (2022)

Equine pituitary pars intermedia dysfunction: Identifying research priorities for diagnosis, treatment and prognosis through a priority setting partnership
por: Tatum, Rebecca C., et al.
Publicado: (2021)

Topical Pergolide Enhance Corneal Nerve Regrowth Following Induced Corneal Abrasion
por: Zhang, Xiaohui, et al.
Publicado: (2020)

Extended-spectrum beta-lactamase (ESBL)-producing Escherichia coli and Acinetobacter baumannii among horses entering a veterinary teaching hospital: The contemporary "Trojan Horse"
por: Walther, Birgit, et al.
Publicado: (2018)

A comparative survey of veterinarians, equine owners, and equine keepers regarding the knowledge and implementation of legal requirements in Germany for the use and documentation of veterinary medicines in equines intended for slaughter
por: Schneider, Shary Tamara, et al.
Publicado: (2023)

Calcium channel currents in pars intermedia cells of the rat pituitary gland. Kinetic properties and washout during intracellular dialysis
Publicado: (1986)

Peptides of the Pars Intermedia. Ciba Foundation Symposium 81
por: Lande, Saul
Publicado: (1981)

Speckle-tracking analysis of myocardial deformation in correlation to age in healthy horses
por: Gehlen, Heidrun, et al.
Publicado: (2018)

Measurement of plasma endothelin-1 concentration in healthy horses and horses with cardiac disease during rest and after exercise
por: GEHLEN, Heidrun, et al.
Publicado: (2018)

Does colonization with MRSA, ESBL – producing Enterobacteriaceae, and/or Acinetobacter baumannii – increase the risk for postoperative surgical site infection?
por: Gehlen, Heidrun, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_lhr440648i05osvlfncviskqsu